T1	Limited_variation	11 30	Rhes ( - / - ) mice
T2	Phenotype	46 73	striatal mTOR signaling and
T3	Disease	85 97	dyskinesia ,
T4	Pharmacodynamic_phenotype	113 150	motor improvement on L-DOPA treatment
T5	Gene_or_protein	190 203	Rhes -binding
T6	Chemical	190 211	Rhes -binding drugs .
R1	decreases	Arg1:T1	Arg2:T2
R2	decreases	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T1	Arg2:T6
R6	isAssociatedWith	Arg1:T2	Arg2:T1
R7	decreases	Arg1:T2	Arg2:T3
R8	isAssociatedWith	Arg1:T2	Arg2:T4
R9	isAssociatedWith	Arg1:T2	Arg2:T5
R10	isAssociatedWith	Arg1:T2	Arg2:T6
R11	isAssociatedWith	Arg1:T3	Arg2:T1
R12	decreases	Arg1:T3	Arg2:T2
R13	isAssociatedWith	Arg1:T3	Arg2:T4
R14	isAssociatedWith	Arg1:T3	Arg2:T5
R15	isAssociatedWith	Arg1:T3	Arg2:T6
R16	isAssociatedWith	Arg1:T4	Arg2:T1
R17	decreases	Arg1:T4	Arg2:T2
R18	decreases	Arg1:T4	Arg2:T3
R19	treats	Arg1:T5	Arg2:T1
R20	decreases	Arg1:T5	Arg2:T2
R21	decreases	Arg1:T5	Arg2:T3
R22	treats	Arg1:T5	Arg2:T4
R23	influences	Arg1:T5	Arg2:T6
R24	isAssociatedWith	Arg1:T6	Arg2:T1
R25	decreases	Arg1:T6	Arg2:T2
R26	decreases	Arg1:T6	Arg2:T3
R27	isAssociatedWith	Arg1:T6	Arg2:T4
R28	influences	Arg1:T6	Arg2:T5
